RHU Coviferon website

15 October 2025 News

We are proud to launch the official website of the RHU COVIFERON Project, a pioneering research initiative dedicated to advancing antiviral therapies and improving patient outcomes.
Here, you will find information about our mission, research goals, clinical studies, and the dedicated teams driving innovation in healthcare.

Stay connected as we share updates, publications, and milestones from the COVIFERON project.
Together, we are shaping the future of medical science.

Discover more. Learn more. Innovate with us.

Other articles

Publications 2 March 2026

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis.

Fulminant viral hepatitis (FVH) is a devastating condition caused by hepatotropic viruses such as hepatitis A virus (HAV), hepatitis B virus (HBV), and HSV-1/2. We studied 149 FVH patients (73 males and 76 females, aged 1-76) for blood autoantibodies (auto-Abs) [...]

Publications 2 March 2026

Expanding the scope of human immunology in the .

The publishes molecular, cellular, and clinical studies of patients with inborn errors of immunity, or their phenocopies, including autoimmune and somatic disorders. A central tenet in the field is that the current range of genetic immunological disorders is only [...]

Publications 2 March 2026

Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV.

Autoantibodies (autoAbs) neutralizing type I interferons (IFN-I) markedly increase the risk of severe manifestations of some viral diseases. The prevalence of autoAbs neutralizing at least one IFN-I, specifically IFN-α2, IFN-β, and IFN-ω, in individuals from the Swiss human immunodeficiency virus [...]

Publications 2 March 2026

Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza.

Avian influenza A virus (IAV) H5N1 is an emerging threat of human pandemic. We describe a 71-year-old man who died of H5N1 pneumonia in Louisiana and whose blood contained autoantibodies neutralizing type I IFNs (AAN-I-IFNs), including the 12 IFN-α subtypes [...]